Multidisciplinary: nanomedicines
HumanAdvanced therapiesRegulatory and procedural guidanceInnovationResearch and developmentScientific guidelines
On Monday, 12 January 2026, between 07:00 and 10:00 CET (Amsterdam time), this website will be unavailable due to scheduled maintenance.
The European Medicines Agency's scientific guidelines on nanomedicines help medicine developers prepare marketing authorisation applications for human medicines.
For a complete list of scientific guidelines currently open for consultation, see Public consultations.
Guidelines
- Data requirements for intravenous iron-based nano-colloidal products developed with reference to an innovator medicinal product
- Data requirements for intravenous liposomal products developed with reference to an innovator liposomal product
- Development of block-copolymer-micelle medicinal products
- Surface coatings: general issues for consideration regarding parenteral administration of coated nanomedicine products